Literature DB >> 17905470

Mucoepidermoid carcinoma of the lung: high-resolution CT and histopathologic findings in five cases.

Taichiro Ishizumi1, Ukihide Tateishi2, Shun-Ichi Watanabe3, Yoshihiro Matsuno4.   

Abstract

OBJECTIVE: The purpose of this study was to characterize the high-resolution computed tomography (HRCT) findings of mucoepidermoid carcinoma of the lung and correlate them with the histopathological features.
METHODS: The study included five patients with pathologically proven mucoepidermoid carcinoma who underwent HRCT before treatment. The HRCT findings were then compared with the histopathological features in all patients.
RESULTS: The HRCT images showed lesions in the central lung in four patients and in the peripheral lung in one. All the lesions were well defined nodules or masses with a smooth margin. The contour of the tumours was oval (n=3), round (n=1) or lobulated (n=1). The contrast-enhanced CT images showed marked heterogeneous enhancement with foci of relatively low attenuation in four of the five lesions and mild heterogeneous enhancement in the other lesion. There was an admixed distribution of areas that are heterogeneous in the densities of blood vessels, as highlighted by immunohistochemical staining of CD31. Most mucin-secreting areas of the tumours showed more densely distributed blood vessels, mostly capillaries, in between tumour cell nests, whereas other areas did less. All five patients in our series underwent lobectomy plus lymph node dissection or sampling. All the patients are alive without evidence of disease an average of 50.4 months after surgery (range, 15-82 months; median, 57 months).
CONCLUSION: Mucoepidermoid carcinoma of the bronchus is often visualized as marked heterogeneous contrast enhancement on HRCT images. The results of this study suggest that the presence of abundant microvessels, detected immunohistochemically by microscopic examination, affects the enhancement pattern on HRCT.

Entities:  

Mesh:

Year:  2007        PMID: 17905470     DOI: 10.1016/j.lungcan.2007.08.022

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  8 in total

1.  A rare case of endobronchial mucoepidermoid carcinoma of the lung presenting as non-resolving pneumonia.

Authors:  Toolsie Omesh; Ranjan Gupta; Anjali Saqi; Joshua Burack; Misbahuddin Khaja
Journal:  Respir Med Case Rep       Date:  2018-08-24

2.  Radiological and Clinical Features and Outcomes of Patients with Primary Pulmonary Salivary Gland-Type Tumors.

Authors:  Xiaoyu Han; Jianchu Zhang; Jun Fan; Yukun Cao; Jin Gu; Heshui Shi
Journal:  Can Respir J       Date:  2019-04-01       Impact factor: 2.409

3.  Dyspnea, focal wheeze, and a slow growing endobronchial tumor.

Authors:  Melanie Chin; Ashish Gupta; Marcio M Gomes; Donna Maziak; Sunita Mulpuru
Journal:  Respir Med Case Rep       Date:  2021-01-30

4.  Predictive CT features for the diagnosis of primary pulmonary mucoepidermoid carcinoma: comparison with squamous cell carcinomas and adenocarcinomas.

Authors:  Xiaohua Ban; Xinping Shen; Huijun Hu; Rong Zhang; Chuanmiao Xie; Xiaohui Duan; Cuiping Zhou
Journal:  Cancer Imaging       Date:  2021-01-06       Impact factor: 3.909

5.  Pulmonary mucoepidermoid carcinoma in the Chinese population: A clinical characteristic and prognostic analysis.

Authors:  Qiuyu Li; Xuejing Wei; Yanfei Wang; Chang Liu; Boshi Fan; Cheng Lv; Wenzhe Si; Min Li
Journal:  Front Oncol       Date:  2022-08-24       Impact factor: 5.738

6.  Bronchial mucoepidermoid carcinoma: A case report.

Authors:  Alessandro G Fois; Gabriella Diana; Antonella Arcadu; Viviana Marras; Paola Crivelli; Carlo Putzu; Giorgio C Ginesu; Sara Canu; Pietro Pirina
Journal:  Int J Surg Case Rep       Date:  2017-01-19

7.  Accidental discovery of a mass on the left main bronchus in a patient undergoing thyroid surgery.

Authors:  Mohammed Abaalkhayl
Journal:  Saudi J Anaesth       Date:  2018 Jul-Sep

8.  Computed tomography-based differentiation of primary pulmonary lymphoepithelioma-like carcinoma and small-cell lung cancer.

Authors:  Kang-Lung Lee; Mei-Han Wu; Ying-Yu Jhang; Chun-Ku Chen; Yi-Chen Yen; Yi-Chun Chen
Journal:  J Chin Med Assoc       Date:  2020-10       Impact factor: 3.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.